Neuroleptic hyperprolactinemia medicamentous correction
The article discusses various aspects of the main approaches to the issue of correction of neuroleptic hyperprolactinemia. Based on the generalized scientific and practical experience, algorithms for corrective therapy with dopamine agonists - bromocriptine and cabergoline (Dostinex) are given. The...
Saved in:
| Main Authors: | L. N. Gorobets, G. E. Mazo |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
2018-07-01
|
| Series: | Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева |
| Subjects: | |
| Online Access: | https://www.bekhterevreview.com/jour/article/view/82 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hyperprolactinemia during application of second-generation antipsychotics: the principles of prevention, diagnosis and correction
by: L. N. Gorobets, et al.
Published: (2018-07-01) -
Sexual differences in the clinical features of antipsychotic-induced hyperprolactinemia in patients with schizophrenia
by: E. G. Kornetova, et al.
Published: (2019-10-01) -
Methods of correction of hyperprolactinemia induced by antipsychotics: current state of the problem and development prospects
by: G. E. Mazo, et al.
Published: (2024-06-01) -
New approaches to pharmacogenetics of drug-induced hyperprolactinemia in patients with schizophrenia
by: S. A. Ivanova
Published: (2019-12-01) -
Bone turnover markers in medicamentous and physiological hyperprolactinemia in female rats
by: Radojković Danijela, et al.
Published: (2014-01-01)